Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.

Bestetti, Reinaldo B; Theodoropoulos, Tatiana A D; Cardinalli-Neto, Augusto; Cury, Patrícia M

Bestetti, Reinaldo B; Theodoropoulos, Tatiana A D; Cardinalli-Neto, Augusto; Cury, Patrícia M.

Affiliation

Bestetti RB; Outpatient Cardiomyopathy Service, Division of Cardiology, São José do Rio Preto Medical School, São José do Rio Preto City, Brazil. rbestetti@netsite.com.br

Am Heart J ; 156(3): 422-30, 2008 Sep.

Article in En | MEDLINE | ID: mdl-18760121

Subject(s)

Cardiology/trends; Chagas Cardiomyopathy/complications; Heart Failure/etiology; Heart Failure/therapy; Adrenergic beta-Antagonists/therapeutic use; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Chronic Disease; Death, Sudden, Cardiac/prevention & control; Defibrillators, Implantable; Disease Progression; Diuretics/therapeutic use; Heart Failure/drug therapy; Heart Failure/physiopathology; Heart Transplantation; Humans; Systole

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiology / Chagas Cardiomyopathy / Heart Failure Limits: Humans Language: En Journal: Am Heart J Year: 2008 Type: Article Affiliation country: Brazil

Fulltext

XML

PubMed Links

Search on Google